Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 72,307 | 78,022 | 152,483 | 178,266 | 208,351 |
| Marketable Securities | N/A | 8,750 | N/A | N/A | N/A |
| Receivables | 8,154 | 17,010 | 28,252 | 28,346 | 28,686 |
| Inventories | 11,024 | 12,166 | 13,278 | 14,159 | 15,230 |
| Other current assets | 0 | 4,348 | 0 | 0 | 0 |
| TOTAL | $97,826 | $127,611 | $202,381 | $230,432 | $257,994 |
| Non-Current Assets | |||||
| PPE Net | 6,854 | 7,230 | 12,194 | 13,020 | 13,773 |
| Intangibles | 21,102 | 21,916 | 26,128 | 27,197 | 28,424 |
| Other Non-Current Assets | 24,767 | 23,962 | 22,848 | 23,652 | 23,370 |
| TOTAL | $52,723 | $53,108 | $61,170 | $63,869 | $65,567 |
| Total Assets | $150,549 | $180,719 | $263,551 | $294,301 | $323,561 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 0 | 3,000 | 2,948 | 0 |
| Accounts payable and accrued liabilities | 81,406 | 99,162 | 105,419 | 97,446 | 93,817 |
| Other current liabilities | 10,448 | 24,759 | 14,982 | 16,917 | N/A |
| TOTAL | $97,351 | $128,583 | $129,473 | $127,715 | $106,303 |
| Non-Current Liabilities | |||||
| Long Term Debt | 45,791 | 46,823 | 91,446 | 93,142 | 92,539 |
| Deferred Revenues | N/A | N/A | 547 | N/A | 1,093 |
| Other Non-Current Liabilities | 26,329 | 55,781 | 56,434 | 53,916 | 53,916 |
| TOTAL | $66,441 | $68,079 | $114,272 | $116,561 | $115,906 |
| Total Liabilities | $163,792 | $196,662 | $243,745 | $244,276 | $222,209 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,943 | 8,857 | 8,960 | 8,655 | 7,245 |
| Common Shares | 9 | 155 | 130 | 7 | 108 |
| Retained earnings | -685,591 | -680,546 | -655,770 | -634,233 | -607,090 |
| Other shareholders' equity | -29,917 | -34,452 | -17,990 | 8,304 | 39,681 |
| TOTAL | $-13,243 | $-15,943 | $19,806 | $50,025 | $101,352 |
| Total Liabilities And Equity | $150,549 | $180,719 | $263,551 | $294,301 | $323,561 |